These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9747820)

  • 61. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effect of combined treatment methods on quality of life in patients with pancreatic cancer].
    Brasiūniene B; Brasiūnas V; Juozaityte E
    Medicina (Kaunas); 2006; 42(10):817-22. PubMed ID: 17090981
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.
    Magnino A; Gatti M; Massucco P; Sperti E; Faggiuolo R; Regge D; Capussotti L; Gabriele P; Aglietta M
    Oncology; 2005; 68(4-6):493-9. PubMed ID: 16020980
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What's new in pancreatic cancer treatment?
    Fung MC; Sakata T
    J Hepatobiliary Pancreat Surg; 2002; 9(1):61-75. PubMed ID: 12021899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In response to Li et al.: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. IJROBP 2003;57:98-104.
    Crane CH
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):1009; author reply 1009-10. PubMed ID: 14967465
    [No Abstract]   [Full Text] [Related]  

  • 66. Neoadjuvant strategies for pancreatic cancer.
    Evans DB; Wolff RA; Crane CH
    Oncology (Williston Park); 2001 Jun; 15(6):727-37; discussion 741-4, 747. PubMed ID: 11430206
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
    Wilkowski R; Thoma M; Bruns C; Wagner A; Heinemann V
    JOP; 2006 Jul; 7(4):349-60. PubMed ID: 16832132
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.
    Taira K; Boku N; Fukutomi A; Onozawa Y; Hironaka S; Yoshino T; Yasui H; Yamazaki K; Taku K; Hashimoto T; Nishimura T
    J Gastroenterol; 2008; 43(11):875-80. PubMed ID: 19012041
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
    Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
    Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer.
    Brasiūniene B; Juozaityte E
    Medicina (Kaunas); 2007; 43(9):716-25. PubMed ID: 17986845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Multimodal therapy for advanced pancreatic cancer].
    Sumii T; Funakoshi A; Iguchi H
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():232-6. PubMed ID: 16457257
    [No Abstract]   [Full Text] [Related]  

  • 72. Future chemoradiation strategies in pancreatic cancer.
    Crane CH; Varadhachary G; Pisters PW; Evans DB; Wolff RA
    Semin Oncol; 2007 Aug; 34(4):335-46. PubMed ID: 17674962
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
    Rich TA; Shepard RC; Mosley ST
    J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.
    Ocean AJ; Pennington KL; Guarino MJ; Sheikh A; Bekaii-Saab T; Serafini AN; Lee D; Sung MW; Gulec SA; Goldsmith SJ; Manzone T; Holt M; O'Neil BH; Hall N; Montero AJ; Kauh J; Gold DV; Horne H; Wegener WA; Goldenberg DM
    Cancer; 2012 Nov; 118(22):5497-506. PubMed ID: 22569804
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Future directions in the treatment of pancreatic cancer.
    Haller DG
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):31-9. PubMed ID: 12577231
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Combined gemcitabine and radiotherapy].
    Mornex F
    Bull Cancer; 2002 Aug; 89 Spec No():S127-33. PubMed ID: 12449044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emerging drugs in pancreatic cancer.
    Ducreux M; Boige V; Malka D
    Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
    Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
    Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.
    Mehta VK; Poen JC; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Fisher GA
    Am J Clin Oncol; 2001 Apr; 24(2):155-9. PubMed ID: 11319291
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Chemotherapy for pancreatic cancer].
    Sunamura M; Egawa S; Fukuyama S; Motoi F; Takeda K; Akada M; Ottomo S; Abe H; Matsuno S
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1901-8. PubMed ID: 14650957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.